[HTA Rapid report- Tecentriq (NSCLC-first line treatment)]
Center for Drug Evaluation
Record ID 32018014667
Chinese (Mandarin)
Details
Project Status:
Completed
Year Published:
2025
URL for published report:
https://www.nhi.gov.tw/ch/dl-84141-0444475e0a234c3ba36e2b71662bc9b4-1.pdf
English language abstract:
There is no English language summary available
Publication Type:
Not Assigned
MeSH Terms
- Carcinoma, Non-Small-Cell Lung
- Lung Neoplasms
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents
- Immune Checkpoint Inhibitors
Contact
Organisation Name:
Center for Drug Evaluation
Contact Address:
3F.,No.465, Sec.6, Zhongxiao E. Rd., Taipei 11557, Taiwan. R.O.C.
Contact Name:
Li Ying (Grace) Huang
Contact Email:
lyhuang277@cde.org.tw
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.